Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yixiao Yan

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Chirality|August 23, 2021
The preparation of optically active epineoclausenamide and enantiomeric separation of its racemateYixiao Yan, Senmei Zhu, Xuna Luo, et al.
ACS Applied Bio Materials|April 28, 2025
Bifunctional Nanostarch against Neuronal Apoptosis via Mitochondria Protection for Ameliorating Ischemic Stroke Injury and Promoting Long-Term Neurological RecoveryJi Xia, Jin Huang, Yixiao Yan, et al.
European Journal of Pharmacology|June 13, 2025
Mendelian randomization analysis with the GEO database: Exploring the molecular mechanism underlying insulin therapy for Perioperative Neurocognitive DisordersChenxin Jian, Ji Xia, Nisha Wang, et al.
Toxicology and Applied Pharmacology|June 2, 2025
Dl-3-n-butylphthalide attenuates acute myocardial infarction by inhibiting the binding of Nrf2/Keap1Yixiao Yan, Zhiqiang Huang, Linting Cheng, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 6, 2021
Bicyclol ameliorates nonalcoholic fatty liver disease in mice via inhibiting MAPKs and NF-κB signaling pathwaysWeixin Zhao, Yixiao Yan, Zhongxiang Xiao, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 9, 2025
Corrigendum to "Bicyclol ameliorates nonalcoholic fatty liver disease in mice via inhibiting MAPKs and NF-κB signaling pathways" [Biomed. Pharmacother. 141 (2021) 1-12/111874]Weixin Zhao, Yixiao Yan, Zhongxiang Xiao, et al.
International Immunopharmacology|November 21, 2025
n-Butylphthalide alleviates obesity-induced cardiomyopathy by binding directly to Keap1Yixiao Yan, Cheng Xiang, Xuelian Wang, et al.
Frontiers in Pharmacology|May 14, 2025
Dl-3-n-butylphthalide attenuates DOX-induced cardiotoxicity in mice by inhibiting Nrf2/Keap1 complex formationYixiao Yan, Mingzhen Fang, Cong Zhao, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 25, 2026
Nature-Inspired Surface Modification Strategy Reverses the Autophagic Flux Impairment of Mitochondrial Transplantation for Attenuating Ischemic StrokesNisha Wang, Qiyang Ding, Lei Shi, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
Multiplexed, scalable analog recording of gene regulation dynamics over weeks using intracellular protein tapesLirong Zheng, Yixiao Yan, Bingxin Zhou, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Chirality|August 23, 2021
The preparation of optically active epineoclausenamide and enantiomeric separation of its racemateYixiao Yan, Senmei Zhu, Xuna Luo, et al.
ACS Applied Bio Materials|April 28, 2025
Bifunctional Nanostarch against Neuronal Apoptosis via Mitochondria Protection for Ameliorating Ischemic Stroke Injury and Promoting Long-Term Neurological RecoveryJi Xia, Jin Huang, Yixiao Yan, et al.
European Journal of Pharmacology|June 13, 2025
Mendelian randomization analysis with the GEO database: Exploring the molecular mechanism underlying insulin therapy for Perioperative Neurocognitive DisordersChenxin Jian, Ji Xia, Nisha Wang, et al.
Toxicology and Applied Pharmacology|June 2, 2025
Dl-3-n-butylphthalide attenuates acute myocardial infarction by inhibiting the binding of Nrf2/Keap1Yixiao Yan, Zhiqiang Huang, Linting Cheng, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 6, 2021
Bicyclol ameliorates nonalcoholic fatty liver disease in mice via inhibiting MAPKs and NF-κB signaling pathwaysWeixin Zhao, Yixiao Yan, Zhongxiang Xiao, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 9, 2025
Corrigendum to "Bicyclol ameliorates nonalcoholic fatty liver disease in mice via inhibiting MAPKs and NF-κB signaling pathways" [Biomed. Pharmacother. 141 (2021) 1-12/111874]Weixin Zhao, Yixiao Yan, Zhongxiang Xiao, et al.
International Immunopharmacology|November 21, 2025
n-Butylphthalide alleviates obesity-induced cardiomyopathy by binding directly to Keap1Yixiao Yan, Cheng Xiang, Xuelian Wang, et al.
Frontiers in Pharmacology|May 14, 2025
Dl-3-n-butylphthalide attenuates DOX-induced cardiotoxicity in mice by inhibiting Nrf2/Keap1 complex formationYixiao Yan, Mingzhen Fang, Cong Zhao, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 25, 2026
Nature-Inspired Surface Modification Strategy Reverses the Autophagic Flux Impairment of Mitochondrial Transplantation for Attenuating Ischemic StrokesNisha Wang, Qiyang Ding, Lei Shi, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
Multiplexed, scalable analog recording of gene regulation dynamics over weeks using intracellular protein tapesLirong Zheng, Yixiao Yan, Bingxin Zhou, et al.
Pageof 2